| http://www.w3.org/ns/prov#value | - Patients likely to receive investigational agents with hepatitis B activity, systemic agents with nephrotoxic potential except immunosuppressive agents or competitors of renal excretion and those requiring chemotherapeutic agents during the course of the study were excluded.
|
